Division of Pathology, Department of Molecular Biology, Medical Biochemistry and Pathology
62nd Carlton-Auger Scientific Day
Gynecological pathology
History of the Carlton-Auger Day
The 62nd Journée scientifique annuelle Carlton-Auger honors the legacy of Dr. Carlton Auger, a towering yet calm figure in pathology. After training at Columbia University in New York, Dr. Auger joined Professor Berger and later succeeded him as head of the department in 1950. His vision reshaped pathology in eastern Quebec, establishing laboratories across regional hospitals and shifting histopathological diagnostics from the university to healthcare centers. A dedicated educator, he launched weekly teaching conferences in 1953—now histoseminars—connecting over 25 hospitals from Trois-Rivières to Gaspé. In 1960, he founded this annual scientific day, renamed in his honor after his passing in 1970. Dr. Auger’s contributions also advanced cancer care, celebrated through the Carlton-Auger Pavilion, built in 1969-70 by the Hôtel-Dieu de Québec (CHUQ) to serve cancer patients. This event continues his mission of knowledge-sharing and innovation in pathology.
Advancing training, innovation and collaboration in pathology
Welcome message from the scientific committee
Dear participants,
It is with great pleasure that we invite you to the 62nd edition of the Carlton-Auger Annual Science Day, which will be held on Saturday, October 4, 2025.
This day is a unique opportunity for the medical-scientific community to come together around a central theme: gynecological pathology. We will have the privilege of welcoming two renowned guest speakers, whose expertise will enrich our program:
-
Dr. Joseph Thomas Rabban III, MD, MPH, Chief of Gynecologic Pathology and Director of the Gynecologic Pathology Fellowship at the University of California, San Francisco (UCSF)
-
Dr. Anjelica Hodgson, MD, FRCPC, FCAP, pathologist at Toronto General Hospital – University Health Network (UHN) and professor in the Department of Laboratory Medicine & Pathobiology
We are confident that this day of stimulating presentations, discussions, and reflections will help deepen your knowledge, enrich your clinical practices, and foster new collaborations.
Thank you for your presence and your continued commitment to the advancement of medical science. Your active participation is central to the success of this event.
We wish you a wonderful scientific day.
Sincerely,
The scientific committee
62nd Annual Carlton-Auger Science Day
General objectives
-
Recognize precursors of endometrioid endometrial carcinoma and various non-neoplastic endometrial lesions that require clinical follow-up.
-
Identify the main diagnostic challenges associated with common uterine mesenchymal lesions.
-
Discuss common cervical lesions and vulvar squamous cell carcinomas.
-
Recognize the main characteristics of clinical presentation, macroscopic appearance, histological features, ancillary tests, differential diagnosis, and/or prognostic and predictive factors for specific pathologies presented in case studies during free oral communications.
-
Discuss ongoing research projects by graduate students and pathology residents (including clinical and basic research projects presented during free communications).
This activity is an accredited group learning activity (Section 1) as defined by the Royal College of Physicians and Surgeons of Canada’s Maintenance of Certification (MOC) Program, as well as a recognized professional development activity (Category A) as defined by the Collège des médecins du Québec. This activity has been approved by the Continuing Professional Development (CPD) Directorate of the Fédération des médecins spécialistes du Québec. You may claim a maximum of 6.5 hours in Section 1 / recognized professional development activity (Category A). Participants must claim a number of hours consistent with the actual duration of their participation.
Program
7:30
Welcome and registration
8:00
Opening remarks
Dr Katherine Grondin
8:10 - 10:00
Free communications by residents and graduate students
Moderator: Dr Andréanne Gagné
8H10
Oral cavity neoplasms: review of the essential elements of the CAP protocol
Dr Cédrik Bouffard
8H20
Breast carcinoma with apocrine differentiation: recognizing the diagnosis and its impact, case report and literature review
Dr Madeleine Picard-Moreau
8H30
Effects of doxycycline on the gastric mucosa, case report and literature review
Dr Mariem Ben Moussa
8H40
Recurrence of Kikuchi-Fujimoto disease presenting as granulomatous appendicitis: case report and literature review
Dr Valentina Parra
8H50
Pulmonary epithelioid hemangioendothelioma – case report of an entity
Dr Michelle Nguyen
9H00
Role of the protein F-box and WD repeat domain containing 4 (FBXW4) and its interactome in the development of focal segmental glomerulosclerosis and split hand/split foot malformation type 3
Dr Samira Slimani
9H10
Composite pheochromocytoma with intermixed ganglioneuroblastoma: case report and literature review
Dr Dominic St-Pierre
Moderator : Dr Marjorie Perron
9H20
Leptomeningeal carcinomatosis: case report and literature review
Dr Michel Fausther
9H30
Characterization of SMARCA4 and SMARCA2 alterations in early-stage pulmonary adenocarcinomas
Jonathan Charron, medical student
9H40
Presentation of a disseminated lupus erythematosus through a neutrophilic dermatosis: case report and literature review
Dr Anne Marie B. Morin
9H50
Revised reports in pathology, quality assurance project
Dr Marie-Maxime Lacombe
10:00
Break and visit the posters
Development and optimization of a 3D in vitro model of an aggressive subtype of prostate cancer
Dr Alexia de Caro
Hypertrophy of mammary adipocytes: a new prognostic biomarker of breast cancer
Ms. Ouafa Badre
10:30 -11:00
Free communications by residents and graduate students
10H30
Case report of microglandular adenosis and literature review
Dr Michael Maranda-Robitaille
10H40
Growing teratoma (growing teratoma syndrome)
Dr Nesrine Kaci
10H50
High-grade endometrioid ovarian carcinoma with pilomatrix-like features, an aggressive and underdiagnosed entity
Dr Cathie Ouellet
11:00
Vulvar squamous neoplasia: Basics and Challenges
Dr Anjelica Hodgson, UHN, Toronto
By the end of the session, the participant will be able to:
-
Appreciate the morphological spectrum of vulvar squamous neoplasia
-
Utilize immunohistochemistry to distinguish between HPV-associated and HPV-independent vulvar intraepithelial neoplasia/squamous cell carcinoma
-
Recognize the clinical importance of distinguishing between HPV-associated and HPV-independent vulvar intraepithelial neoplasia/squamous cell carcinoma
11:45
Q & A session
12:00
Lunch
13:30
Practical approach to common challenges and dilemmas in endometrial biopsies
Dr Joseph Rabban, UCSF, San Francisco
By the end of the session, the participant will be able to:
-
Apply World Health Organization criteria to classify precursors of endometrioid carcinoma and their mimics.
-
Recognize non-neoplastic endometrial alterations that may carry risk of under-sampled endometrial cancer.
-
Discuss the current literature on evaluation of specimens submitted for concern of chronic endometritis.
14:15
Q & A session
14:30
Uterine leiomyoma variants that mimic potentially aggressive mesenchymal tumors
Dr Joseph Rabban, UCSF, San Francisco
By the end of the session, the participant will be able to:
-
Apply World Health Organization criteria to classify the malignant potential of uterine smooth muscle tumors.
-
Recognize common pitfalls in the interpretation of atypia, mitoses, and necrosis in uterine leiomyoma.
-
Utilize a pattern-based approach to determine when work up is needed for aggressive uterine mesenchymal tumors that may mimic leiomyoma.
-
Select and interpret biomarkers to work up aggressive mimics of uterine leiomyoma.
15:15
Q & A session
15:30
Break
16:00
Navigating the spectrum of cervical glandular neoplasia
Dr Anjelica Hodgson, UHN, Toronto
By the end of the session, the participant will be able to:
-
Classify endocervical glandular neoplasms according to WHO criteria
-
Apply the pattern-based classification system for HPV-associated adenocarcinomas
-
Resolve cervical adenocarcinoma staging conundrums
16:45
Q & A session
17:00
Closing remarks and presentation of excellence awards to residents and graduate students
17:20
Completion of activity evaluation form
17:30
End of Activity
Speakers
Dre Anjelica Hodgson, MD, FRCPC
Gynecologic Pathologist
Laboratory Medicine Program
UHN, Toronto
Dr. Anjelica Hodgson, originally from Ottawa, Ontario, did her pathology training and the University of Toronto and Memorial Sloan Kettering Cancer Center and now practices as a specialist in gynecologic pathology at Toronto General Hospital (University Health Network). She is an assistant professor in the University of Toronto's Department of Laboratory Medicine and Pathobiology. Her research primarily focuses on the classification and prognostication of cervical adenocarcinomas and she is an expert author for multiple chapters on cervical adenocarcinoma in the upcoming World Health Organization 6th Edition book on the classification of Tumours of the Female Genital Tract. Other areas of academic interest include uterine mesenchymal tumours and the spectrum of vulvar squamous neoplasia.
Dr Joseph T Rabban, MD, MPH
Professor
Anatomic Pathology
UCSF, San Francisco
Dr Rabban is Professor of Pathology and Director of Gynecological Pathology at the University of California San Francisco where he also directs the Gynecological Pathology Fellowship. He is an editor and author of the 5th and 6th editions of the World Health Organization Classification of Female Genital Tumors; Associate Editor of the International Journal of Gynecological Pathology; and member of numerous committees including the USCAP Education Committee and the American Board of Pathology test development and advisory committee. Dr Rabban's research focuses on diagnostic pathology of the endometrium, myometrium, ovary, and trophoblast, as well as hereditary tumor syndromes
Event venue
Room 4511 – Le Cercle
Located on the 4th floor of the
Alphonse-Desjardins Pavilion
Université Laval
2305 Rue de l'Université
Québec, QC G1V 0B3, Canada
Scientific committee
Julie Riopel, MD, FRCPC
Pathologist - Head of the Continuing Professional Development Committee
Department of Molecular Biology, Medical Biochemistry and Pathology
Université Laval
Conflict of interest
Andrey-Ann Galibois, MD
Breast pathologist and deputy head of department
Department of Pathology and Cytology
Université Laval
Andréanne Gagné, MD, PhD
Pathologist and clinical physician teaching under grant
Department of Molecular Biology, Medical Biochemistry and Pathology
Université Laval
Conflict of interest
Katherine Grondin, M.D., PhD
Gynecologic Pathologist
CHU de Québec – Université Laval
Michel Fausther, M.D., PhD
Resident
Université Laval
Conflict of interest
Juliana Jaques Do Amaral, MD
Resident
Residency Program in Diagnostic and Molecular Pathology
Université Laval
Conflict of interest
Sponsors
This content was developed by the 62nd Carlton-Auger Scientific Day thanks to unrestricted funding from the following sponsors:
SILVER: AstraZeneca, Merck Canada
BRONZE: Roche, AbbVie
CONTRIBUTOR : GSK
The sponsors played no role in the development of the content, the choice of topics, or the selection of speakers. The views expressed in this presentation are solely those of the authors/speakers.